Nestle under new CEO Laurent Freixe is rebasing the medium-term organic growth target after multi-year underperformance versus historical peer norms. Pricing-led growth is rolling off into a volume-recovery phase that has been uneven. Strategic priorities (coffee, pet food, nutritional health) remain solid but execution requires multi-year investment in advertising and innovation. L'Oreal stake remains a hidden asset (~CHF20bn) and source of optionality. Defensive dividend yield ~3.5% provides a floor.
| Ticker | Company | Score | Gap | Signal Δ | Action |
|---|---|---|---|---|---|
| DIS | The Walt Disney Company | 47 | +12% | ↑2% | EARLY |
| GM | General Motors Company | 47 | +12% | ↑2% | NEUTRAL |
| DEO | Diageo PLC | 47 | +8% | ↑2% | NEUTRAL |
| BTI | British American Tobacco PLC | 47 | +14% | ↑2% | EARLY |
| LI | Li Auto Inc | 47 | +7% | ↑2% | NEUTRAL |
| F | Ford Motor Company | 47 | +12% | ↑2% | NEUTRAL |
| ROST | Ross Stores Inc. | 47 | +8% | ↑2% | EARLY |
Nestle accelerates A&P investment under new CEO to drive volume recovery
Nestle Health Science strategic review may yield divestments
Estimates · Yahoo Finance · Not audited figures